Michigan Molecular Institute (Midland, MI) earned U.S. Patent 7,794,699 for  nano-structured blood substitutes. According to inventors Steven N. Kaganove,  Paul Satoh,  Petar R. Dvornic, the nano-structured blood substitute represents an improved synthetic blood substitute which exhibits excellent long-term storage stability at both high and low temperatures is suitable for use…

Read More

A team of Welsh scientists have successfully cloned a human virus offering new hope for the treatment of potentially life-threatening diseases. Human cytomegalovirus is a major infectious cause of congenital malformations worldwide. The virus is also known to cause life-threatening disease in transplant patients and people with HIV/AIDS.  Human cytomegalovirus…

Read More